A novel approach to oral apoA-I mimetic therapy

High-Density Lipoprotein and 4F Peptide Reduce Systemic Inflammation by Modulating Intestinal Oxidized Lipid Metabolism

(2012) Mohamad Navab et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Identification of genes affecting apolipoprotein B secretion following siRNA-mediated gene knockdown in primary human hepatocytes

(2012) Xun Shen et al.   ATHEROSCLEROSIS

Biliary and nonbiliary contributions to reverse cholesterol transport

(2012) Ryan E. Temel et al.   CURRENT OPINION IN LIPIDOLOGY

Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma

(2012) Xianglan Yao et al.   Frontiers in Pharmacology

Reverse Cholesterol Transport Revisited

(2011) Gemma Brufau et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein A-1 (apoA-1) deposition in, and release from, the enterocyte brush border: A possible role in transintestinal cholesterol efflux (TICE)?

(2011) E. Michael Danielsen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Lipoprotein-Derived Lysophosphatidic Acid Promotes Atherosclerosis by Releasing CXCL1 from the Endothelium

(2011) Zhe Zhou et al.   Cell Metabolism

L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways

(2011) Feng Gao et al.   Integrative Biology

D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice

(2011) Mohamad Navab et al.   JOURNAL OF LIPID RESEARCH

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally

(2011) Mohamad Navab et al.   JOURNAL OF LIPID RESEARCH

Rapid determination of lycopene and β-carotene in tomato by liquid chromatography/electrospray tandem mass spectrometry

(2011) Luigi Lucini et al.   JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE

Novel HDL-directed pharmacotherapeutic strategies

(2011) Emil M. deGoma et al.   Nature Reviews Cardiology

Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes

(2010) C. Morgantini et al.   DIABETES

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function

(2010) Catherine E. Watson et al.   JOURNAL OF LIPID RESEARCH

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

(2010) F. Su et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Structure and Function of HDL Mimetics

(2009) Mohamad Navab et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids

(2009) Mohamad Navab et al.   JOURNAL OF LIPID RESEARCH

Improved lycopene extraction from tomato peels using cell-wall degrading enzymes

(2008) Roberto Lavecchia et al.   EUROPEAN FOOD RESEARCH AND TECHNOLOGY

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I

(2008) Brian J. Van Lenten et al.   JOURNAL OF LIPID RESEARCH

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

(2008) LeAnne T. Bloedon et al.   JOURNAL OF LIPID RESEARCH